GST

Anrok announces Series B participation from Intuit Ventures

Retrieved on: 
Mittwoch, Mai 29, 2024

Anrok , the global sales tax platform for software companies, shared today that Intuit Ventures has participated in its Series B funding round.

Key Points: 
  • Anrok , the global sales tax platform for software companies, shared today that Intuit Ventures has participated in its Series B funding round.
  • Khosla Ventures was the lead investor in the round, announced last month .
  • Intuit Ventures is a natural partner and investor for Anrok,” said Michelle Valentine, Anrok’s co-founder and CEO.
  • “Intuit has been helping small businesses with their overall financial compliance for decades, but sales tax is a particularly challenging problem for software companies and distributed teams.” said Adam Coccari, Managing Director at Intuit Ventures.

Hydreight Technologies through its associated Medical network now offer Tirzepatide to Product Offering which also features GLP-1 Medications (Low-Cost Semaglutide), NAD+ and more

Retrieved on: 
Donnerstag, Mai 23, 2024

GLP-1 drugs work by mimicking the hormone GLP-1, resulting in weight loss, lowering hemoglobin A1c (HbA1c) and reducing cardiovascular risks.

Key Points: 
  • GLP-1 drugs work by mimicking the hormone GLP-1, resulting in weight loss, lowering hemoglobin A1c (HbA1c) and reducing cardiovascular risks.
  • The burgeoning weight-loss drug industry could be worth as much as $100 billion by 2030, according to Goldman Sachs .
  • Over 3,000 nurses, 107 white-label locations and their patients now have access to Tirzepatide through the Hydreight platform and its associated Medical network in over 700 cities across 50 states in the United States.
  • Tirzepatide is in the same product line as Semaglutide,which was launched and accessible via the Hydreight platform at the end of 2023 .

Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates

Retrieved on: 
Mittwoch, Mai 15, 2024

BOTHELL, Wash., May 15, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results for the quarter ended March 31, 2024, and provided recent pipeline and business updates.

Key Points: 
  • Athira expects to report topline data from LIFT-AD in the second half of 2024.
  • Athira expects to initiate a first-in-human study of ATH-1105 in the second quarter of 2024.
  • R&D expenses were $21.2 million for the quarter ended March 31, 2024, compared to $21.3 million for the quarter ended March 31, 2023.
  • G&A expenses were $6.5 million for the quarter ended March 31, 2024, compared to $8.5 million for the quarter ended March 31, 2023.

New board members appointed to Habitat for Humanity Canada’s National Board of Directors

Retrieved on: 
Mittwoch, Mai 15, 2024

TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Habitat for Humanity Canada held its annual general meeting on May 10 and local Habitat for Humanity organizations from across Canada elected four new and returning members to Habitat Canada’s National Board of Directors.

Key Points: 
  • TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- Habitat for Humanity Canada held its annual general meeting on May 10 and local Habitat for Humanity organizations from across Canada elected four new and returning members to Habitat Canada’s National Board of Directors.
  • “It is my pleasure to welcome new and returning members to our National Board of Directors,” says Julia Deans, President and CEO of Habitat for Humanity Canada.
  • Habitat Canada thanks retiring board members David Sauve, Imran Thaver and Marie Claire Uwanyirigira for their service on the national board and commitment to Habitat for Humanity’s vision of a world where everyone has a decent place to live.
  • For a complete list of Habitat Canada’s National Board of Directors and their roles, visit https://habitat.ca/en/about-us/our-team

Netcracker Showcases the Power of Data to Build Customer Loyalty and Drive Profitability at Telecoms World Middle East

Retrieved on: 
Mittwoch, Mai 15, 2024

Netcracker Technology announced today that it will highlight its expertise in helping telcos identify new monetization opportunities at Telecoms World Middle East on May 28-29 in Dubai.

Key Points: 
  • Netcracker Technology announced today that it will highlight its expertise in helping telcos identify new monetization opportunities at Telecoms World Middle East on May 28-29 in Dubai.
  • Netcracker will highlight its groundbreaking portfolio, including Netcracker Digital Platform and Netcracker GenAI Telco Solution , which is designed to drive business growth and provide a superior customer experience throughout the digital transformation process.
  • Netcracker is a Diamond Partner of the event and will exhibit in stand D40.
  • Netcracker will also participate in the following sessions with other industry leaders, including customers Etisalat by e&, Vodafone Oman and Zain KSA:
    Tuesday, May 28 | 9:20 a.m. GST
    Khalid Murshed, Chief Technology & Information Officer, Etisalat by e&
    Tuesday, May 28 | 3:20 p.m. GST
    Wednesday, May 29 | 11:20 a.m. GST

XCath to Perform Live Telerobotic Trial Procedure at Abu Dhabi Global Healthcare Week

Retrieved on: 
Dienstag, Mai 14, 2024

XCath , an early-stage medical device company dedicated to expanding endovascular treatment modalities through its smart steerable guidewires and robotic systems, will exhibit its technology through innovation sessions at Abu Dhabi Global Healthcare Week (ADGHW) hosted by the Abu Dhabi Department of Health (DoH).

Key Points: 
  • XCath , an early-stage medical device company dedicated to expanding endovascular treatment modalities through its smart steerable guidewires and robotic systems, will exhibit its technology through innovation sessions at Abu Dhabi Global Healthcare Week (ADGHW) hosted by the Abu Dhabi Department of Health (DoH).
  • The demonstration will include a live telerobotic trial procedure between Abu Dhabi and South Korea on May 15th at 11:00 am GST, demonstrating the XCath platform’s potential to support remote minimally invasive procedures for the management of acute neurovascular conditions.
  • Dr. Vitor Mendes Pereira, Director of Endovascular Research and Innovation at St. Michael’s Hospital in Toronto, Canada, will perform the live trial demonstration.
  • ADGHW will take place May 13-15 in Abu Dhabi, uniting global healthcare leaders, policymakers and stakeholders to examine worldwide trends and industry challenges.

Nagarro announces Q1 '24 results, posts profitable growth

Retrieved on: 
Dienstag, Mai 14, 2024

In Q1 2024, revenue grew to €238.3 million, up 7.6% QoQ from €221.4 million in Q4 2023 and up 8.7% QoQ in constant currency.

Key Points: 
  • In Q1 2024, revenue grew to €238.3 million, up 7.6% QoQ from €221.4 million in Q4 2023 and up 8.7% QoQ in constant currency.
  • Gross margin remained the same as in Q1 2023 at 26.8% (as per the previous method) and was 30.9% in Q1 2024 (as per the current method).
  • Adjusted EBITDA grew by €7.8 million from €31.4 million (13.7% of revenue) in Q1 2023 to €39.2 million (16.4% of revenue) in Q1 2024.
  • * Nagarro has revised the definition of cost of revenues from Q1 2024 onwards to align it better with that of other IT services companies.

Nagarro announces Q1 '24 results, posts profitable growth

Retrieved on: 
Dienstag, Mai 14, 2024

In Q1 2024, revenue grew to €238.3 million, up 7.6% QoQ from €221.4 million in Q4 2023 and up 8.7% QoQ in constant currency.

Key Points: 
  • In Q1 2024, revenue grew to €238.3 million, up 7.6% QoQ from €221.4 million in Q4 2023 and up 8.7% QoQ in constant currency.
  • Gross margin remained the same as in Q1 2023 at 26.8% (as per the previous method) and was 30.9% in Q1 2024 (as per the current method).
  • Adjusted EBITDA grew by €7.8 million from €31.4 million (13.7% of revenue) in Q1 2023 to €39.2 million (16.4% of revenue) in Q1 2024.
  • * Nagarro has revised the definition of cost of revenues from Q1 2024 onwards to align it better with that of other IT services companies.

Minister of Justice and Attorney General of Canada announces a judicial appointment to the Tax Court of Canada

Retrieved on: 
Montag, Mai 13, 2024

OTTAWA, ON, May 13, 2024 /CNW/ - The Honourable Arif Virani, Minister of Justice and Attorney General of Canada, today announced the following appointment under the judicial application process established in 2016.

Key Points: 
  • OTTAWA, ON, May 13, 2024 /CNW/ - The Honourable Arif Virani, Minister of Justice and Attorney General of Canada, today announced the following appointment under the judicial application process established in 2016.
  • Michael U. Ezri, General Counsel at the Department of Justice Canada in Toronto, is appointed a Judge of the Tax Court of Canada.
  • He has argued significant and high-profile tax cases before the Tax Court of Canada, the Federal Court, and the Federal Court of Appeal.
  • Budget 2022 provides for 22 new judicial positions, along with two associate judges at the Tax Court of Canada.

Lionsgate and Stern Pinball’s New John Wick Pinball Games Ready to Infiltrate Homes and Arcades Worldwide

Retrieved on: 
Dienstag, Mai 7, 2024

Stern Pinball, Inc. announces its newest line of pinball games featuring the world’s greatest assassin, John Wick.

Key Points: 
  • Stern Pinball, Inc. announces its newest line of pinball games featuring the world’s greatest assassin, John Wick.
  • John Wick pinball games are available in Pro, Premium, and Limited Edition (LE) models.
  • View the full release here: https://www.businesswire.com/news/home/20240507230616/en/
    In Stern’s John Wick pinball games, players step into the role of the world’s greatest assassin as he fights to escape his past.
  • The John Wick pinball games will feature original neo-noir style paintings illustrated by acclaimed artist, Randy Martinez.